Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. Oktober 2007 08:00 ET | Quelle: BioForce Nanosciences Holdings, Inc.

BioForce Nanosciences Holdings, Inc. Announces Notice of Allowance for Its Sindex Chip Patent

AMES, Iowa, Oct. 25, 2007 (PRIME NEWSWIRE) -- BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), a company focused on the development and commercialization of nanotech tools and solutions for the life...
23. Oktober 2007 09:17 ET | Quelle: Infinity Pharmaceuticals, Inc.

Infinity and MedImmune Announce Issuance of U.S. Patent for Proprietary Heat Shock Protein 90 Inhibitors

CAMBRIDGE, Mass. and GAITHERSBURG, Md., Oct. 23, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) and MedImmune, Inc. today announced that the United States Patent and Trademark...
23. Oktober 2007 08:17 ET | Quelle: Rockwell Medical, Inc.

Rockwell Medical Technologies, Inc. Receives Patent Grant for Proprietary SFP Iron-Delivery in Mexico

WIXOM, Mich., Oct. 23, 2007 (PRIME NEWSWIRE) -- Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a leading, innovative manufacturer and developer of renal drug therapies and essential dialysate...
16. Oktober 2007 14:00 ET | Quelle: Cytomedix, Inc.

Cytomedix Licenses Technology Patent to Smith & Nephew

ROCKVILLE, Md., Oct. 16, 2007 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX:GTF) today announced that it has entered into a licensing agreement with Smith & Nephew, Inc., a global medical technology...
16. Oktober 2007 08:30 ET | Quelle: Immunomedics, Inc.

Immunomedics Awarded U.S. Patent for Humanized PAM4 Monoclonal Antibody and Its Use in the Diagnosis and Therapy of Pancreatic Cancer

MORRIS PLAINS, N.J., Oct. 16, 2007 (PRIME NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious...
15. Oktober 2007 08:41 ET | Quelle: BioForce Nanosciences Holdings, Inc.

BioForce Nanosciences Announces Confirmation of Its Nanoarray Patent

AMES, Iowa, Oct. 15, 2007 (PRIME NEWSWIRE) -- BioForce Nanosciences, Inc., a wholly-owned subsidiary of BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), today announced that it has received notice...
04. Oktober 2007 03:13 ET | Quelle: Epigenomics AG

Epigenomics AG: Key Patents For Cancer Testing Granted

BERLIN and SEATTLE, Oct. 4, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX) (ISIN: DE000A0BVT96) today announced that key patents covering Epigenomics' core technology HeavyMethyl(r) for the...
03. Oktober 2007 08:30 ET | Quelle: Penwest Pharmaceuticals Co.

Penwest Announces Issuance of Patent Related to OPANA ER

DANBURY, Conn., Oct. 3, 2007 (PRIME NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced the issuance by the U.S. Patent and Trademark Office (USPTO) of U.S. Patent No. 7276250,...
02. Oktober 2007 08:55 ET | Quelle: Generex Biotechnology Corp.

Generex Biotechnology Awarded United States Patent

WORCESTER, Mass., Oct. 2, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced...
26. September 2007 01:38 ET | Quelle: MorphoSys AG

MorphoSys Granted Further U.S. Patent for Its Core Antibody Technology HuCAL

MARTINSRIED, Germany, Sept. 26, 2007 (PRIME NEWSWIRE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment) announced today that the U.S. Patent & Trademark Office has granted a fifth U.S....

Vorherige Seite

Nächste Seite